Answers are grounded in this paper and cite their sources.
AL amyloidosis is a protein-misfolding disorder caused by deposition of immunoglobulin light-chain variable domains. Lambda chains account for ≈80% of cases and kappa for ≈20%. We performed high-resolution mass spectrometry and bioinformatics on biopsies from 25 patients (15 kappa-type, 9 lambda-type, 1 mixed). We identified 42 unique IGKV and 11 IGLV sequences; IGKV3-20, IGKV1-39/1D-39, and IGLV1-40 were most frequent. Because immunoglobulin variable-domain sequences are highly homologous, some identifications are reported at the family or subfamily level. Amino acid substitutions clustered in FR1 and FR3. Using FoldAmyloid, PASTA, AGGRESCAN, and Waltz, we evaluated the amyloidogenicity of native and mutant proteins. Several mutations altered aggregation: I70/54V in IGKV1-27 abolished Waltz-predicted amyloidogenic stretch, while T42/22L in IGKV1-5 created a new AGGRESCAN hotspot. Notably, eight identified sequences (IGKV3-7, IGKV1/OR2-108, IGKV6D-21, IGKV6-21, IGKV1D-42, IGKV6D-41, IGKV3/OR2-268, IGLV1-50) are absent from the AL-Base database, suggesting that rare germline variants may carry a higher amyloidogenic risk. Our study underscores the value of combining proteomics and computational analysis for precise amyloid typing and for identifying mutations that may influence disease progression.
No takes yet. Share an insight, caveat, or question.
Suvorina et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: